Niramas Utama Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Niramas Utama Tbk. trades at Rp1,005 (market cap 1.31T, 64.48M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 8.7× Niramas Utama Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (64.48M versus 1.77M). Which is the better fit depends on your goals.
| JELI | TSPC | |
|---|---|---|
Market Cap | 1.31T | 11.36T |
Volume | 64.48M | 1.77M |
Lot | 644.81K | 17.71K |
Turnover | 65.83B | 4.61B |
Average Price | 1,020.91 | 2,603.9 |
Value | 65.83B | 4.61B |
Indicative Equilibrium Price | 1,005 | 2,590 |
Indicative Equilibrium Volume | 24.22K | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →